Nothing Special   »   [go: up one dir, main page]

RU2018118958A - Репрезентативная диагностика - Google Patents

Репрезентативная диагностика Download PDF

Info

Publication number
RU2018118958A
RU2018118958A RU2018118958A RU2018118958A RU2018118958A RU 2018118958 A RU2018118958 A RU 2018118958A RU 2018118958 A RU2018118958 A RU 2018118958A RU 2018118958 A RU2018118958 A RU 2018118958A RU 2018118958 A RU2018118958 A RU 2018118958A
Authority
RU
Russia
Prior art keywords
homogenate
data
cell
cell structures
sample
Prior art date
Application number
RU2018118958A
Other languages
English (en)
Other versions
RU2743169C2 (ru
RU2018118958A3 (ru
Inventor
Нельсон АЛЕКСАНДЕР
Аоун БАРХОУМИ
Мелинда ДЭЙ
Лиза ГАЛЛЕГОС
Кэтрин ЛИТ
Саманта РАЖКОВИЧ
Эстебан РОБЕРТС
Стейси СТАНИСЛАВ
Эрик УОЛК
Original Assignee
Вентана Медикал Системз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вентана Медикал Системз, Инк. filed Critical Вентана Медикал Системз, Инк.
Publication of RU2018118958A publication Critical patent/RU2018118958A/ru
Publication of RU2018118958A3 publication Critical patent/RU2018118958A3/ru
Application granted granted Critical
Publication of RU2743169C2 publication Critical patent/RU2743169C2/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
    • A01N1/0226—
    • A01N1/0278—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/34—Purifying; Cleaning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/36—Embedding or analogous mounting of samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/4833—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
    • G01N2001/2866—Grinding or homogeneising
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
    • G01N2001/2873—Cutting or cleaving
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G01N2001/302—Stain compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/36—Embedding or analogous mounting of samples
    • G01N2001/368—Mounting multiple samples in one block, e.g. TMA [Tissue Microarrays]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)

Claims (22)

1. Обработанный гомогенат, приготовленный из образца гетерогенной ткани, содержащий по существу гомогенно распределенные клеточные структуры, где соотношение клеточных структур в каждой подгруппе гомогената по существу аналогично соотношению клеточных структур в образце ткани.
2. Гомогенат по п. 1, где образец ткани выбран из группы, состоящей из: опухоли, лимфатического узла, метастаза, полипа, кисты, извлеченного резекцией материала, органа или их доли.
3. Гомогенат по п. 1 или 2, где образец ткани содержит пространственно обособленные клеточные структуры.
4. Гомогенат по любому из пп. 1-3, где клеточные структуры содержат кластер клеток, отдельную клетку, фрагмент клетки, органеллу, пептид, нуклеиновую кислоту, липид, метаболит или их комбинацию.
5. Гомогенат по любому из пп. 1-4, где гомогенат содержит до 25% включительно клеточных структур из образца ткани.
6. Гомогенат по любому из пп. 1-4, где гомогенат содержит 100% клеточных структур из образца ткани.
7. Гомогенат по любому из пп. 1-6, где гомогенат дополнительно содержит один или более чем один материал, выбранный из клетки, не являющейся клеткой человека, человеческой клетки, ненативного белка, нуклеиновых кислот или малой молекулы, красителя, вируса, бактерии, паразита, представителя простейших или химического вещества.
8. Композиция по п. 7, где малая молекула содержит гаптен, пептидную метку, белковую метку, флуоресцентную метку, нуклеиновокислотную метку и их комбинацию.
9. Способ получения репрезентативных данных, включающий анализ гомогената по любому из пп. 1-8.
10. Способ по п. 9, где анализ включает получение количественных и/или качественных данных для маркера в гомогенате.
11. Способ по п. 10, где маркер содержит ДНК, белок, РНК, липид, клеточную органеллу, метаболит или клетку.
12. Способ по п. 9, дополнительно включающий сравнение репрезентативных данных с предварительно заданным значением для этих данных.
13. Способ по п. 12, где предварительно заданное значение выбрано из данных клинических испытаний, данных для субъекта, данных из научной литературы, данных для находящейся в клинической разработке биологической или малой молекулы.
14. Способ по п. 9, где репрезентативные данные содержат репрезентативные онкологические данные, при этом репрезентативные онкологические данные содержат количественные и/или качественные данные по меньшей мере для одного опухолевого маркера из первого биологического образца, при этом указанный опухолевый маркер ассоциирован с наличием опухоли, включающий:
(a) измерение опухолевого маркера в первом биологическом образце, при этом измеренное значение для опухолевого маркера является нормированным;
(b) получение суммарной оценки в баллах на основании этого нормированного измеренного значения; и
(c) сравнение суммарной оценки в баллах с предварительно заданной оценкой в баллах с целью определения показателя риска рака у субъекта.
15. Способ определения фенотипического профиля образца ткани, который включает анализ клеточных структур гомогената по п. 1.
16. Способ приготовления гомогената по п. 1, включающий:
a) гомогенизацию образца;
b) реконструирование гомогенизированного образца с получением гомогената, причем указанный гомогенат содержит по существу гомогенные клеточные структуры,
при этом соотношение клеточных структур в подгруппе гомогената по существу аналогично или равно соотношению клеточных структур в образце ткани.
RU2018118958A 2015-11-06 2016-11-07 Репрезентативная диагностика RU2743169C2 (ru)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201562252153P 2015-11-06 2015-11-06
US62/252,153 2015-11-06
US201662279405P 2016-01-15 2016-01-15
US62/279,405 2016-01-15
US201662354622P 2016-06-24 2016-06-24
US62/354,622 2016-06-24
US201662418146P 2016-11-04 2016-11-04
US62/418,146 2016-11-04
PCT/US2016/060861 WO2017079763A1 (en) 2015-11-06 2016-11-07 Representative diagnostics

Publications (3)

Publication Number Publication Date
RU2018118958A true RU2018118958A (ru) 2019-12-06
RU2018118958A3 RU2018118958A3 (ru) 2020-03-11
RU2743169C2 RU2743169C2 (ru) 2021-02-15

Family

ID=57406344

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018118958A RU2743169C2 (ru) 2015-11-06 2016-11-07 Репрезентативная диагностика

Country Status (13)

Country Link
US (2) US11959838B2 (ru)
EP (1) EP3371594A1 (ru)
JP (4) JP7094880B2 (ru)
KR (2) KR102696044B1 (ru)
CN (2) CN114480574A (ru)
AU (2) AU2016349644B2 (ru)
BR (1) BR112018009071B1 (ru)
CA (1) CA3004504A1 (ru)
IL (3) IL298356B2 (ru)
MX (2) MX2018004838A (ru)
RU (1) RU2743169C2 (ru)
WO (1) WO2017079763A1 (ru)
ZA (1) ZA201802493B (ru)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4321627A3 (en) 2015-04-10 2024-04-17 10x Genomics Sweden AB Spatially distinguished, multiplex nucleic acid analysis of biological specimens
RU2743169C2 (ru) 2015-11-06 2021-02-15 Вентана Медикал Системз, Инк. Репрезентативная диагностика
GB201615532D0 (en) * 2016-09-13 2016-10-26 Univ Swansea Computer-Implemented apparatus and method for performing a genetic toxicity assay
WO2018157048A1 (en) 2017-02-24 2018-08-30 Massachusetts Institute Of Technology Methods for examining podocyte foot processes in human renal samples using conventional optical microscopy
WO2018157074A1 (en) * 2017-02-24 2018-08-30 Massachusetts Institute Of Technology Methods for diagnosing neoplastic lesions
EP3610265A1 (en) 2017-04-14 2020-02-19 Ventana Medical Systems, Inc. Size-based separation of dissociated fixed tissues
EP3662443A2 (en) * 2017-08-04 2020-06-10 Ventana Medical Systems, Inc. Automated methods and systems for detecting cells in stained specimen images
US20220065863A1 (en) * 2017-12-11 2022-03-03 Georgetown University Predictive biomarkers for adverse effects of radiation therapy
US11873374B2 (en) 2018-02-06 2024-01-16 Massachusetts Institute Of Technology Swellable and structurally homogenous hydrogels and methods of use thereof
CN108610409B (zh) * 2018-04-09 2021-08-24 深圳大学 Etv5在制备预防或治疗肥胖症及相关代谢性疾病药物中的应用
CN108593380B (zh) * 2018-04-25 2021-05-18 复旦大学附属中山医院 一种组织芯片量产制作方法
CN112534439A (zh) * 2018-07-27 2021-03-19 文塔纳医疗系统公司 用于自动化原位杂交分析的系统
JP7259019B2 (ja) * 2018-09-20 2023-04-17 ヴェンタナ メディカル システムズ， インク． フローサイトメトリデータを分析するためのサイズに基づくゲーティング
CN112789684A (zh) 2018-10-01 2021-05-11 文塔纳医疗系统公司 用于预测对pd-1轴导向疗法的应答的方法和系统
CN109298730A (zh) * 2018-11-07 2019-02-01 上海坤爱生物科技股份有限公司 一种组织样品恒温消化过程的可控制装置
CN109406789A (zh) * 2018-11-23 2019-03-01 李翀 一种膀胱癌循环细胞检测试剂盒及应用
JP7479367B2 (ja) * 2018-11-29 2024-05-08 ヴェンタナ メディカル システムズ， インク． 代表的なＤＮＡシーケンシングによる個別化されたｃｔＤＮＡ疾患のモニタリング
US11592657B2 (en) 2018-12-18 2023-02-28 Hemotech Cognition, LLC Method and system for identifying objects in a blood sample
US11714088B2 (en) * 2019-02-19 2023-08-01 Univerisy of South Carolina Early detection of colorectal cancer
US20230159995A1 (en) * 2019-02-28 2023-05-25 10X Genomics, Inc. Profiling of biological analytes with spatially barcoded oligonucleotide arrays
CN109884163B (zh) * 2019-03-10 2021-09-17 复旦大学 一种外膜蛋白酶t酶解组蛋白并进行质谱分析的方法
RU2718284C1 (ru) * 2019-04-12 2020-04-01 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Способ скринингового определения вероятности наличия рака мочевого пузыря
CN109975097A (zh) * 2019-04-18 2019-07-05 山东师范大学 一种基于适配体的肿瘤细胞染色探针组合
EP4013896A4 (en) * 2019-08-12 2023-09-20 Baylor College of Medicine PROTEOGENOMIC METHODS FOR CANCER DIAGNOSIS
CN110387419B (zh) * 2019-08-20 2023-06-13 裕策医疗器械江苏有限公司 实体瘤多基因检测基因芯片及其制备方法和检测装置
CN110927387B (zh) * 2019-11-08 2022-05-20 江苏大学 一种brca2蛋白酶联免疫双抗夹心试剂盒及其应用
WO2021113505A1 (en) 2019-12-05 2021-06-10 Massachusetts Institute Of Technology Method for preparing a specimen for expansion microscopy
CN115461470A (zh) * 2020-02-28 2022-12-09 10X基因组学有限公司 用于从组织中分离核和细胞的方法
US11238583B2 (en) * 2020-03-25 2022-02-01 City University Of Hong Kong System and method for generating a stained image
CN115552248A (zh) * 2020-05-07 2022-12-30 文塔纳医疗系统公司 用于评价肿瘤样品中egfr和egfr配体表达的组织化学系统和方法
WO2021236929A1 (en) 2020-05-22 2021-11-25 10X Genomics, Inc. Simultaneous spatio-temporal measurement of gene expression and cellular activity
US12031177B1 (en) 2020-06-04 2024-07-09 10X Genomics, Inc. Methods of enhancing spatial resolution of transcripts
CN111849918A (zh) * 2020-07-24 2020-10-30 扬州大学 一种研究鸡SSCs中受组蛋白甲基化调控的靶基因的方法
CN112052813B (zh) * 2020-09-15 2023-12-19 中国人民解放军军事科学院军事医学研究院 染色体间易位识别方法、装置、电子设备及可读存储介质
US20230375556A1 (en) * 2020-10-12 2023-11-23 Mgi Tech Co., Ltd. Protein detection and tracking using nucleoside tags
CN112284850B (zh) * 2020-10-22 2021-05-18 四川大学华西医院 一种消化内科活体取样后的智能分析前端处理设备
CN112326539A (zh) * 2020-10-28 2021-02-05 中国科学院生态环境研究中心 一种全器官细胞增殖定量检测方法
US20220206002A1 (en) * 2020-12-30 2022-06-30 Uttam K. Sinha Systems and methods for detecting substances in a fluid using tapered fibers
CA3201131A1 (en) * 2020-12-31 2022-07-07 Catherine M. Shachaf Systems and methods for assessing tissue remodeling
EP4294571B8 (en) 2021-02-19 2024-07-10 10X Genomics, Inc. Method of using a modular assay support device
JP2022131579A (ja) 2021-02-26 2022-09-07 キオクシア株式会社 分析装置および分析方法
JP2024522336A (ja) * 2021-05-14 2024-06-18 ジェネンテック， インコーポレイテッド デジタル病理画像からのアクショナブル変異の予測
CN113281441A (zh) * 2021-05-19 2021-08-20 中国科学技术大学 单细胞器质谱检测方法、检测装置
EP4124622A1 (en) * 2021-07-29 2023-02-01 Fondazione IRCCS Istituto Nazionale dei Tumori Rapid histological diagnosis for oncology therapy
WO2023023064A1 (en) * 2021-08-17 2023-02-23 Gopath Laboratories, Llc Methods and materials for predicting the progression of prostate cancer and treating same
WO2023177707A1 (en) * 2022-03-16 2023-09-21 The Regents Of The University Of California Methods and systems for microbial tumor hypoxia diagnostics and theranostics
CN115938490B (zh) * 2023-03-07 2023-06-06 之江实验室 一种基于图表示学习算法的代谢物鉴定方法、系统和设备
WO2024215528A1 (en) 2023-04-13 2024-10-17 Ventana Medical Systems, Inc. Proliferation assay for fixed solid tumors
CN116769975B (zh) * 2023-08-15 2023-11-24 江苏美克医学技术有限公司 Hpv检测引物组、试剂盒及其应用

Family Cites Families (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130101A (en) 1961-08-11 1964-04-21 William G Gittins Manufacture of plastic covered panels for use in building construction
US4469797A (en) 1982-09-23 1984-09-04 Miles Laboratories, Inc. Digoxigenin immunogens, antibodies, labeled conjugates, and related derivatives
US4616658A (en) * 1985-02-27 1986-10-14 William Shell Non-radioactively labeled microspheres and use of same to measure blood flow
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4774339A (en) 1987-08-10 1988-09-27 Molecular Probes, Inc. Chemically reactive dipyrrometheneboron difluoride dyes
DE3836656A1 (de) 1988-10-27 1990-05-03 Boehringer Mannheim Gmbh Neue digoxigenin-derivate und ihre verwendung
US5132432A (en) 1989-09-22 1992-07-21 Molecular Probes, Inc. Chemically reactive pyrenyloxy sulfonic acid dyes
US5433896A (en) 1994-05-20 1995-07-18 Molecular Probes, Inc. Dibenzopyrrometheneboron difluoride dyes
US5274113A (en) 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5248782A (en) 1990-12-18 1993-09-28 Molecular Probes, Inc. Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
US5338854A (en) 1991-02-13 1994-08-16 Molecular Probes, Inc. Fluorescent fatty acids derived from dipyrrometheneboron difluoride dyes
WO1992020781A1 (en) * 1991-05-17 1992-11-26 Park Pharmaceuticals, Inc. Atp extraction reagent containing ammonium vanadate
US5187288A (en) 1991-05-22 1993-02-16 Molecular Probes, Inc. Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
US5262357A (en) 1991-11-22 1993-11-16 The Regents Of The University Of California Low temperature thin films formed from nanocrystal precursors
US5505928A (en) 1991-11-22 1996-04-09 The Regents Of University Of California Preparation of III-V semiconductor nanocrystals
US6048616A (en) 1993-04-21 2000-04-11 Philips Electronics N.A. Corp. Encapsulated quantum sized doped semiconductor particles and method of manufacturing same
US5843644A (en) 1994-03-01 1998-12-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Isolation of cellular material under microscopic visualization using an adhesive/extraction reagent tipped probe
WO1996000283A1 (en) 1994-06-24 1996-01-04 Boehringer Mannheim Corporation A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum
US5571018A (en) 1994-11-23 1996-11-05 Motorola, Inc. Arrangement for simulating indirect fire in combat training
US5690807A (en) 1995-08-03 1997-11-25 Massachusetts Institute Of Technology Method for producing semiconductor particles
US5800996A (en) 1996-05-03 1998-09-01 The Perkin Elmer Corporation Energy transfer dyes with enchanced fluorescence
US5696157A (en) 1996-11-15 1997-12-09 Molecular Probes, Inc. Sulfonated derivatives of 7-aminocoumarin
US5830912A (en) 1996-11-15 1998-11-03 Molecular Probes, Inc. Derivatives of 6,8-difluoro-7-hydroxycoumarin
US5866366A (en) 1997-07-01 1999-02-02 Smithkline Beecham Corporation gidB
US6130101A (en) 1997-09-23 2000-10-10 Molecular Probes, Inc. Sulfonated xanthene derivatives
US6322901B1 (en) 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
US5990479A (en) 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6617583B1 (en) 1998-09-18 2003-09-09 Massachusetts Institute Of Technology Inventory control
US6372937B1 (en) 1998-11-09 2002-04-16 Mark Norman Bobrow Enhanced catalyzed reporter deposition
US6114038A (en) 1998-11-10 2000-09-05 Biocrystal Ltd. Functionalized nanocrystals and their use in detection systems
US6855202B2 (en) 2001-11-30 2005-02-15 The Regents Of The University Of California Shaped nanocrystal particles and methods for making the same
US6238922B1 (en) * 1999-02-26 2001-05-29 Stemcells, Inc. Use of collagenase in the preparation of neural stem cell cultures
AU4701200A (en) 1999-05-07 2000-11-21 Quantum Dot Corporation A method of detecting an analyte using semiconductor nanocrystals
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US20050112141A1 (en) * 2000-08-30 2005-05-26 Terman David S. Compositions and methods for treatment of neoplastic disease
US6248535B1 (en) 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
US6306736B1 (en) 2000-02-04 2001-10-23 The Regents Of The University Of California Process for forming shaped group III-V semiconductor nanocrystals, and product formed using process
US6225198B1 (en) 2000-02-04 2001-05-01 The Regents Of The University Of California Process for forming shaped group II-VI semiconductor nanocrystals, and product formed using process
JP2004500109A (ja) 2000-03-22 2004-01-08 クァンタム・ドット・コーポレイション ビーズベースの核酸アッセイにおける半導体ナノクリスタルの使用方法
EP1286705A2 (en) 2000-06-01 2003-03-05 The Board Of Regents Of Oklahoma State University Bioconjugates of nanoparticles as radiopharmaceuticals
ATE415399T1 (de) 2000-08-04 2008-12-15 Molecular Probes Inc Kondensierte ringe enthaltende 1,2-dihydro-7- hydroxychinolinderivate
US6649138B2 (en) 2000-10-13 2003-11-18 Quantum Dot Corporation Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media
US20020083888A1 (en) 2000-12-28 2002-07-04 Zehnder Donald A. Flow synthesis of quantum dot nanocrystals
EP1368497A4 (en) 2001-03-12 2007-08-15 California Inst Of Techn METHOD AND DEVICE FOR ANALYZING POLYNUCLEOTIDE SEQUENCES BY ASYNCHRONOUS BASE EXTENSION
US6709929B2 (en) 2001-06-25 2004-03-23 North Carolina State University Methods of forming nano-scale electronic and optoelectronic devices using non-photolithographically defined nano-channel templates
ATE556845T1 (de) 2001-07-20 2012-05-15 Life Technologies Corp Lumineszierende nanopartikel und ihre herstellung
CA2474960A1 (en) * 2002-02-01 2003-08-07 Thomas Jefferson University Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
WO2003087766A2 (en) 2002-04-05 2003-10-23 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets
CN1488639A (zh) * 2002-10-09 2004-04-14 上海市刑事科学技术研究所 从组织样品中分离rna的方法
DE10261529A1 (de) * 2002-12-23 2004-07-08 Indivumed Gmbh Verfahren zur Erstellung einer Sammlung von biologischem Probenmaterial und Probensammlung
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
JPWO2005094887A1 (ja) 2004-03-31 2008-02-14 第一製薬株式会社 ｓＦＲＰ発現増強剤
CA2563613A1 (en) * 2004-04-16 2005-12-08 Wei-Sing Chu Device for extracting biological molecules from tissue specimens
DK1978993T3 (en) 2005-10-31 2017-03-20 Oncomed Pharm Inc Compositions and Methods for Treating Cancer Based on Human FZD Receptors
BRPI0709397A2 (pt) 2006-03-13 2011-07-05 Veridex Llc propagação de células primárias
CA2995467C (en) 2006-11-01 2020-03-10 Ventana Medical Systems, Inc. Haptens, hapten conjugates, compositions thereof and method for their preparation and use
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
EP2677309B9 (en) 2006-12-14 2014-11-19 Life Technologies Corporation Methods for sequencing a nucleic acid using large scale FET arrays, configured to measure a limited pH range
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
ES2319039B1 (es) 2007-05-07 2010-03-03 Alvaro Martins-Ferreira Alemao Procedimiento para el rastreo y diagnostico precoz del cancer colorrectal.
JP5388297B2 (ja) 2007-06-08 2014-01-15 株式会社バイオマスター アディポクラスター
EP2027922A1 (de) 2007-08-02 2009-02-25 Qiagen GmbH Verfahren und Vorrichtung für das Fixieren/Stabilisieren einer Probe
US8592150B2 (en) 2007-12-05 2013-11-26 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
US20100029498A1 (en) 2008-02-04 2010-02-04 Andreas Gnirke Selection of nucleic acids by solution hybridization to oligonucleotide baits
US20100035252A1 (en) 2008-08-08 2010-02-11 Ion Torrent Systems Incorporated Methods for sequencing individual nucleic acids under tension
US8546128B2 (en) 2008-10-22 2013-10-01 Life Technologies Corporation Fluidics system for sequential delivery of reagents
US20100137143A1 (en) 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US20100301398A1 (en) 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
EP3388509A1 (en) 2008-11-12 2018-10-17 inRegen Isolated renal cells and uses thereof
EP2396661A4 (en) * 2009-02-11 2013-10-30 Caris Mpi Inc MOLECULAR PROFILING OF TUMORS
US8574835B2 (en) 2009-05-29 2013-11-05 Life Technologies Corporation Scaffolded nucleic acid polymer particles and methods of making and using
US8673627B2 (en) 2009-05-29 2014-03-18 Life Technologies Corporation Apparatus and methods for performing electrochemical reactions
CN102498129B (zh) * 2009-07-31 2016-03-02 霍夫曼-拉罗奇有限公司 使用bv8拮抗剂或g-csf拮抗剂抑制肿瘤转移
CN101955541B (zh) * 2010-05-06 2012-10-03 北京维德维康生物技术有限公司 一种检测克伦特罗的免疫试剂盒及其专用抗体
KR102315754B1 (ko) 2010-05-14 2021-10-22 더 제너럴 하스피톨 코포레이션 종양 특이적 신생항원을 확인하는 조성물 및 방법
JP2013531801A (ja) 2010-07-02 2013-08-08 ヴェンタナ メディカル システムズ， インク． 標的検出のためのハプテンコンジュゲート
EP2689787A1 (en) * 2010-09-03 2014-01-29 Stem Centrx, Inc. Identification and enrichment of cell subpopulations
US20150045232A1 (en) * 2010-12-28 2015-02-12 Bexmart Integrated and versatile methods for systems diagnosis of diseases
AU2012205849A1 (en) 2011-01-10 2013-07-04 Ventana Medical Systems, Inc. Hematoxylin staining method
CA2742342A1 (en) 2011-02-12 2012-08-12 Baylor Research Institute Msh3 expression status determines the responsiveness of cancer cells to the chemotherapeutic treatment with parp inhibitors and platinum drugs
US9448231B2 (en) 2011-02-28 2016-09-20 Ventana Medical Systems, Inc. Application of quantum dots for nuclear staining
CA2830140C (en) 2011-03-16 2019-08-06 Tohoku University Probe for analyzing biological tissue and method for utilizing same
WO2012129008A1 (en) 2011-03-18 2012-09-27 Baylor Research Institute Line-1 hypomethylation as a biomarker for early-onset colorectal cancer
WO2012154552A1 (en) 2011-05-06 2012-11-15 Phylonix Pharmaceuticals, Inc. Method and device for removing particles from liquid and placing them into a holding device
ES2589507T3 (es) 2011-05-09 2016-11-14 Ventana Medical Systems, Inc. Obtención de imágenes espectrales para la medición de características patológicas nucleares en células de cáncer preparadas para el análisis in situ
FR2976076B1 (fr) 2011-05-31 2015-02-27 Imabiotech Procede de detection et de quantification d'une molecule cible dans un tissu
FR2977674B1 (fr) 2011-07-06 2015-08-14 Cisbio Bioassays Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule
WO2013019945A2 (en) 2011-08-02 2013-02-07 Clovis Oncology, Inc.. Method for selection of chemotherapeutic agents for adenocarcinoma cancer
CN103045467B (zh) * 2011-10-13 2014-05-14 徐仰德 生物医学均质装置
GB2497510A (en) 2011-11-10 2013-06-19 Harry Cuppens Methods for determining mononucleotide sequence repeats
WO2013079606A1 (en) 2011-12-01 2013-06-06 Ventana Medical Systems, Inc. Automated dual stain of mirna and protein targets
US20130252240A1 (en) 2012-03-21 2013-09-26 Ventana Medical Systems, Inc. Cryoembedded cell concentrates, methods for making, and methods for using
JP6253657B2 (ja) 2012-10-08 2017-12-27 ヴェンタナ メディカル システムズ， インク． 有色素サンプルを明確化するための方法、キット、及びシステム
US9080167B2 (en) * 2012-11-16 2015-07-14 Covaris, Inc. System and method for processing paraffin embedded samples
EP2738557A1 (en) 2012-12-03 2014-06-04 Université Libre de Bruxelles Organized immune response in cancer
DE102012023929B4 (de) 2012-12-06 2014-12-31 Maria Rogmans Verfahren zum Betrieb einer aquatischen Pflanzenkultureinrichtung für Futtermittel, sowie Pflanzenkultureinrichtung selbst
US10138519B2 (en) 2012-12-28 2018-11-27 Quest Diagnostics Investments Incorporated Universal sanger sequencing from next-gen sequencing amplicons
RU2521239C1 (ru) 2013-02-26 2014-06-27 Федеральное государственное бюджетное учреждение науки Институт биологии развития им. Н.К. Кольцова Российской академии наук (ФГБУН Институт биологии развития им. Н.К. Кольцова РАН) Способ интраоперационной диагностики рака щитовидной железы
WO2014139979A1 (en) 2013-03-12 2014-09-18 Ventana Medical Systems, Inc. Quantum dot in situ hybridization
US20140278461A1 (en) 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center System and method for integrating a medical sequencing apparatus and laboratory system into a medical facility
ES2649616T3 (es) 2013-06-17 2018-01-15 Hans U. Baer Matriz e implante para ingeniería de tejidos
CN105873639A (zh) 2013-09-27 2016-08-17 万科斯诺晋国际合作有限公司 自体肿瘤疫苗和方法
WO2015052128A1 (en) 2013-10-07 2015-04-16 Ventana Medical Systems, Inc. Systems and methods for comprehensive multi-assay tissue analysis
CN105793689B (zh) 2013-10-18 2020-04-17 七桥基因公司 用于将遗传样本基因分型的方法和系统
US20170173180A1 (en) 2014-03-27 2017-06-22 The Regents Of The University Of Michigan Cancer immunotherapy compositions and methods
WO2015150278A1 (en) 2014-03-31 2015-10-08 Ventana Medical Systems, Inc. Automated specimen processing systems and multistep processing of microscope slides
CA2944829C (en) 2014-05-23 2022-10-25 Ting Chen Systems and methods for detection of biological structures and/or patterns in images
CA2947926C (en) 2014-06-27 2020-03-10 Ventana Medical Systems, Inc. Automated specimen processing systems and methods of detecting specimen-bearing microscope slides
RU2743169C2 (ru) 2015-11-06 2021-02-15 Вентана Медикал Системз, Инк. Репрезентативная диагностика

Also Published As

Publication number Publication date
EP3371594A1 (en) 2018-09-12
RU2743169C2 (ru) 2021-02-15
CN108449995B (zh) 2022-02-01
NZ741539A (en) 2024-03-22
IL298356A (en) 2023-01-01
IL290309B1 (en) 2023-12-01
IL298356B2 (en) 2024-09-01
JP7212024B2 (ja) 2023-01-24
AU2016349644B2 (en) 2022-11-24
KR20240122584A (ko) 2024-08-12
JP2019503474A (ja) 2019-02-07
AU2016349644A1 (en) 2018-04-19
US20240210288A1 (en) 2024-06-27
MX2018004838A (es) 2019-07-18
CN114480574A (zh) 2022-05-13
JP2022191274A (ja) 2022-12-27
BR112018009071A8 (pt) 2019-02-26
BR112018009071A2 (pt) 2018-10-30
MX2022001954A (es) 2022-05-11
IL290309B2 (en) 2024-04-01
CA3004504A1 (en) 2017-05-11
JP7094880B2 (ja) 2022-07-04
JP2024037825A (ja) 2024-03-19
AU2022268299A1 (en) 2022-12-15
KR102696044B1 (ko) 2024-08-16
CN108449995A (zh) 2018-08-24
US20200049599A1 (en) 2020-02-13
IL258418A (en) 2018-05-31
BR112018009071B1 (pt) 2021-12-14
JP2021060405A (ja) 2021-04-15
RU2018118958A3 (ru) 2020-03-11
WO2017079763A1 (en) 2017-05-11
ZA201802493B (en) 2019-01-30
JP7402289B2 (ja) 2023-12-20
KR20180081561A (ko) 2018-07-16
US11959838B2 (en) 2024-04-16
IL258418B (en) 2022-03-01
IL298356B1 (en) 2024-05-01
IL290309A (en) 2022-04-01

Similar Documents

Publication Publication Date Title
RU2018118958A (ru) Репрезентативная диагностика
Wühr et al. Accurate multiplexed proteomics at the MS2 level using the complement reporter ion cluster
Dejung et al. Quantitative proteomics uncovers novel factors involved in developmental differentiation of Trypanosoma brucei
Zhu et al. Single-neuron identification of chemical constituents, physiological changes, and metabolism using mass spectrometry
Eritano et al. Tissue-scale mechanical coupling reduces morphogenetic noise to ensure precision during epithelial folding
JP2020514746A5 (ru)
HRP20191182T1 (hr) Identifikacija tumorsko-zaštitnih epitopa za liječenje karcinoma
US20150199474A1 (en) Methods and systems for aligning sequences in the presence of repeating elements
JP2017061448A5 (ru)
KR20160068953A (ko) 질환-유도된 돌연변이를 확인하기 위한 방법 및 시스템
Keup et al. Multimodal targeted deep sequencing of circulating tumor cells and matched cell-free DNA provides a more comprehensive tool to identify therapeutic targets in metastatic breast cancer patients
Jeong et al. GCC2 as a new early diagnostic biomarker for non-small cell lung cancer
Minutolo et al. Identification and characterization of citrus concave gum-associated virus infecting citrus and apple trees by serological, molecular and high-throughput sequencing approaches
WO2020061251A8 (en) High throughput method and system for mapping intracellular phase diagrams
Wang et al. Universal, label-free, single-molecule visualization of DNA origami nanodevices across biological samples using origamiFISH
van Ineveld et al. Multispectral confocal 3D imaging of intact healthy and tumor tissue using mLSR-3D
Thilly et al. Metakaryotic stem cell nuclei use pangenomic dsRNA/DNA intermediates in genome replication and segregation
Amaya et al. Proteomic strategies for the discovery of novel diagnostic and therapeutic targets for infectious diseases
Sabzevari et al. A serological study of Leishmania infantum in dogs of Khorasan Razavi province, Iran
Pozniak et al. Design and application of super-SILAC for proteome quantification
Anjo et al. Neuroproteomics using short GeLC-SWATH: from the evaluation of proteome changes to the clarification of protein function
Rantala et al. Expanding the diversity of imaging-based RNAi screen applications using cell spot microarrays
Ge et al. Multi-omics analysis to visualize ecotype-specific heterogeneity of the metabolites in the mesocarp tissue of three avocado (Persea americana Mill.) ecotypes
Jabart et al. Single-cell protein expression of hiPSC-derived cardiomyocytes using Single-Cell Westerns
Pavlova et al. Immunocytological analysis of chromatin in isolated nuclei